Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent Chemotherapy in Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating definitive hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy for cervical cancer is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Samsung Medical Center | Conditions: Cervical Cancer | Phase 2 | Status: RECRUITING